Skip to main content

The administration of hepatocyte growth factor prevents total parenteral nutrition-induced hepatocellular injury in a rat model

Abstract

Purpose

Total parenteral nutrition (TPN) sometimes induces parenteral nutrition-associated liver disease (PNALD). Hepatocyte growth factor (HGF) acts as a potent hepatocyte mitogen anti-inflammatory and antioxidant actions. We aimed to evaluate the effect of HGF on PNALD in a rat model of TPN.

Methods

A catheter was placed in the right jugular vein for 7-day continuous TPN. All rats were divided into three groups: TPN alone (TPN group), TPN plus intravenous HGF at 0.3 mg/kg/day [TPN + HGF (low) group], and TPN plus HGF at 1.0 mg/kg/day [TPN + HGF (high) group]. On day 7, livers were harvested and the histology, inflammatory cytokines and apoptosis were evaluated.

Results

Histologically, lipid droplets were apparent in the TPN group, but decreased in the TPN + HGF (low) and TPN + HGF (high) groups. The histological nonalcoholic fatty liver disease activity scores in the TPN + HGF (low) and TPN + HGF (high) groups were significantly lower than that in the TPN group (p < 0.01). There were no significant differences in the inflammatory cytokine levels of the three groups. The caspase-9 expression levels in the TPN + HGF (low) and TPN + HGF (high) groups were significantly decreased in comparison to that in the control group (p < 0.05).

Conclusion

The intravenous administration of HGF attenuated hepatic steatosis induced by 7-day TPN dose dependently.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Baker AL, Rosenberg IH (1987) Hepatic complications of total parenteral nutrition. Am J Med 82(3):489–497

    CAS  PubMed  Article  Google Scholar 

  2. Kumar JA, Teckman JH (2015) Controversies in the mechanism of total parenteral nutrition induced pathology. Children (Basel, Switzerland) 2(3):358–370

    Google Scholar 

  3. Wales PW, Allen N, Worthington P, George D, Compher C, Teitelbaum D (2014) A.S.P.E.N. clinical guidelines: support of pediatric patients with intestinal failure at risk of parenteral nutrition-associated liver disease. J Parenter Enteral Nutr 38(5):538–557

    Article  Google Scholar 

  4. Onishi S, Kaji T, Yamada W, Nakame K, Moriguchi T, Sugita K, Yamada K, Kawano T, Mukai M, Souda M, Yamada S, Yoshioka T, Tanimoto A, Ieiri S (2016) The administration of ghrelin improved hepatocellular injury following parenteral feeding in a rat model of short bowel syndrome. Pediatr Surg Int 32(12):1165–1171

    PubMed  Article  Google Scholar 

  5. Machigashira S, Kaji T, Onishi S, Yamada W, Yano K, Yamada K, Masuya R, Kawano T, Nakame K, Mukai M, Ieiri S (2018) The protective effect of fish oil lipid emulsions on intestinal failure-associated liver disease in a rat model of short-bowel syndrome. Pediatr Surg Int 34(2):203–209

    PubMed  Article  Google Scholar 

  6. Yano K, Kaji T, Onishi S, Machigashira S, Nagai T, Harumatsu T, Yamada K, Yamada W, Muto M, Nakame K, Mukai M, Ieiri S (2019) Novel effect of glucagon-like peptide-2 for hepatocellular injury in a parenterally fed rat model of short bowel syndrome. Pediatr Surg Int 35(12):1345–1351

    PubMed  Article  Google Scholar 

  7. Cao X, Feng F, Liu X, Sun C, Yang X, Fang Y, Li S (2020) Exogenous secretin improves parenteral nutrition-associated liver disease in rats. J Pediatr Gastroenterol Nutr 70(4):430–435

    CAS  PubMed  Article  Google Scholar 

  8. Yamada W, Kaji T, Onishi S, Nakame K, Yamada K, Kawano T, Mukai M, Souda M, Yoshioka T, Tanimoto A, Ieiri S (2016) Ghrelin improves intestinal mucosal atrophy during parenteral nutrition: an experimental study. J Pediatr Surg 51(12):2039–2043

    PubMed  Article  Google Scholar 

  9. Gohda E, Tsubouchi H, Nakayama H, Hirono S, Sakiyama O, Takahashi K, Miyazaki H, Hashimoto S, Daikuhara Y (1988) Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Investig 81(2):414–419

    CAS  PubMed  Article  Google Scholar 

  10. Nasu Y, Ido A, Tanoue S, Hashimoto S, Sasaki F, Kanmura S, Setoyama H, Numata M, Funakawa K, Moriuchi A, Fujita H, Sakiyama T, Uto H, Oketani M, Tsubouchi H (2013) Hepatocyte growth factor stimulates the migration of gastric epithelial cells by altering the subcellular localization of the tight junction protein ZO-1. J Gastroenterol 48(2):193–202

    CAS  PubMed  Article  Google Scholar 

  11. Setoyama H, Ido A, Numata M, Moriuchi A, Yamaji N, Tamai T, Funakawa K, Fujita H, Sakiyama T, Uto H, Oketani M, Tsubouchi H (2011) Repeated enemas with hepatocyte growth factor selectively stimulate epithelial cell proliferation of injured mucosa in rats with experimental colitis. Life Sci 89(7–8):269–275

    CAS  PubMed  Article  Google Scholar 

  12. Komaki Y, Kanmura S, Sasaki F, Maeda H, Oda K, Arima S, Tanoue S, Nasu Y, Hashimoto S, Mawatari S, Tsubouchi H, Ido A (2019) Hepatocyte growth factor facilitates esophageal mucosal repair and inhibits the submucosal fibrosis in a rat model of esophageal ulcer. Digestion 99(3):227–238

    CAS  PubMed  Article  Google Scholar 

  13. Motoi S, Toyoda H, Obara T, Ohta E, Arita Y, Negishi K, Moriya K, Kuboi Y, Soejima M, Imai T, Ido A, Tsubouchi H, Kawano T (2019) Anti-apoptotic effects of recombinant human hepatocyte growth factor on hepatocytes were associated with intrahepatic hemorrhage suppression indicated by the preservation of prothrombin time. Int J Mol Sci 20(8):1821

    CAS  PubMed Central  Article  Google Scholar 

  14. Tahara M, Matsumoto K, Nukiwa T, Nakamura T (1999) Hepatocyte growth factor leads to recovery from alcohol-induced fatty liver in rats. J Clin Investig 103(3):313–320

    CAS  PubMed  Article  Google Scholar 

  15. Sugimoto T, Yamashita S, Ishigami M, Sakai N, Hirano K, Tahara M, Matsumoto K, Nakamura T, Matsuzawa Y (2002) Decreased microsomal triglyceride transfer protein activity contributes to initiation of alcoholic liver steatosis in rats. J Hepatol 36(2):157–162

    CAS  PubMed  Article  Google Scholar 

  16. Kosone T, Takagi H, Horiguchi N, Ariyama Y, Otsuka T, Sohara N, Kakizaki S, Sato K, Mori M (2007) HGF ameliorates a high-fat diet-induced fatty liver. Am J Physiol Gastrointest Liver Physiol 293(1):G204-210

    CAS  PubMed  Article  Google Scholar 

  17. Kusumoto K, Ido A, Moriuchi A, Katsura T, Kim I, Takahama Y, Numata M, Kodama M, Hasuike S, Nagata K, Uto H, Inui K, Tsubouchi H (2006) Repeated intravenous injection of recombinant human hepatocyte growth factor ameliorates liver cirrhosis but causes albuminuria in rats. Int J Mol Med 17(3):503–509

    CAS  PubMed  Google Scholar 

  18. Miyazawa K, Tsubouchi H, Naka D, Takahashi K, Okigaki M, Arakaki N, Nakayama H, Hirono S, Sakiyama O, Takahashi K et al (1989) Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 163(2):967–973

    CAS  PubMed  Article  Google Scholar 

  19. Nabeshima A, Yamada S, Guo X, Tanimoto A, Wang KY, Shimajiri S, Kimura S, Tasaki T, Noguchi H, Kitada S, Watanabe T, Fujii J, Kohno K, Sasaguri Y (2013) Peroxiredoxin 4 protects against nonalcoholic steatohepatitis and type 2 diabetes in a nongenetic mouse model. Antioxid Redox Signal 19(17):1983–1998

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  20. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226(1):497–509

    CAS  PubMed  Article  Google Scholar 

  21. Ogura Y, Hamanoue M, Tanabe G, Mitsue S, Yoshidome S, Nuruki K, Aikou T (2001) Hepatocyte growth factor promotes liver regeneration and protein synthesis after hepatectomy in cirrhotic rats. Hepatogastroenterology 48(38):545–549

    CAS  PubMed  Google Scholar 

  22. Kaibori M, Kwon AH, Oda M, Kamiyama Y, Kitamura N, Okumura T (1998) Hepatocyte growth factor stimulates synthesis of lipids and secretion of lipoproteins in rat hepatocytes. Hepatology 27(5):1354–1361

    CAS  PubMed  Article  Google Scholar 

  23. He XL, He YM, Zhang D, Li HS, Zhang Q, Yuan SS, Zhang Z, Wang YY, Liu CH, Fan CH, Li YH, Zheng M, Yang HJ, Zhou P (2020) Efficacy and mechanism of a chinese classic prescription of Yueju in treating nonalcoholic steatohepatitis and protecting hepatocytes from apoptosis. Evid Based Complement Altern Med 2020:8888040

    Google Scholar 

  24. Tilg H, Moschen AR (2010) Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52(5):1836–1846

    CAS  Article  Google Scholar 

Download references

Acknowledgements

We thank Mr. Brain Quinn for his comments and help with the manuscript. This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS: 20K08934, 20K17558, 20K22958, 19K10485, 19K09150, 19K09078, 19K03084, 19K18061, 19K17304, 19K18032, 18K08578, 18K16262 17K10555, 17K11514, 17K10183, 17K11515, 16K10466, 16K10094, 16K10095, 16K10434, 16H07090), a Grant for Experimental Research in the Japanese Society for Parenteral & Enteral Nutrition, research grant from Kagoshima Prefecture Medical Association, research grant from The Mother and Child Health Foundation and research grant from Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Satoshi Ieiri.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest in association with the present study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Matsukubo, M., Yano, K., Kaji, T. et al. The administration of hepatocyte growth factor prevents total parenteral nutrition-induced hepatocellular injury in a rat model. Pediatr Surg Int 37, 353–361 (2021). https://doi.org/10.1007/s00383-020-04823-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00383-020-04823-9

Keywords

  • Total parenteral nutrition
  • Steatosis
  • Hepatocyte growth factor
  • PNALD
  • NAFLD